Reuters logo
BRIEF-Enlivex Therapeutics announces closing of $8 mln Series B round led by KIP and HBL
September 19, 2017 / 11:34 AM / 3 months ago

BRIEF-Enlivex Therapeutics announces closing of $8 mln Series B round led by KIP and HBL

Sept 19 (Reuters) - HBL Hadasit Bio Holdings Ltd

* Enlivex Therapeutics announces closing of $8 mln Series B round led by Korea Investment Partners (KIP) and Hadasit Bio Holdingings Ltd. (HBL)

* ‍Enlivex Therapeutics - following closing of $8 mln Series B round, Korea Investment Partners has appointed two new members to Enlivex’s board Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below